GlassScriptPhysician profile
Yingqiu Xia
NPI 1568758076
$4,441.95
in general payments reported to CMS, 2019-2025
16 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $714 · 2021: $387 · 2022: $381 · 2023: $748 · 2024: $486 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,610.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,807.15 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,148.19 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $390.00 | 2020-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $222.69 | 2020-2023 | Nucala |
| Optinose US, INC. | $215.25 | 2019-2020 | |
| Amgen INC. | $209.08 | 2020-2021 | |
| Axsome Therapeutics, INC. | $125.00 | 2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $96.38 | 2019 | |
| Exact Sciences Corporation | $56.93 | 2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $35.98 | 2019 | |
| Alk-Abello, INC | $33.58 | 2020-2021 | |
| Gilead Sciences, INC. | $24.39 | 2021 | |
| Merck Sharp & Dohme LLC | $24.07 | 2023 | |
| Verona Pharma, INC. | $22.79 | 2025 | Ohtuvayre |
| Circassia INC. | $17.40 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yingqiu Xia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.